Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2004 | 06-2004 | 03-2004 | 12-2003 | 09-2003 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,491 | 6,148 | 8,356 | 727 | 446 |
| Marketable Securities | 535 | 969 | 939 | 1,860 | 3,915 |
| Receivables | 819 | 1,128 | 1,189 | 1,149 | 642 |
| Inventories | 153 | 108 | 108 | 185 | 345 |
| TOTAL | $6,772 | $9,291 | $11,680 | $4,819 | $5,948 |
| Non-Current Assets | |||||
| PPE Net | 1,090 | 981 | 1,009 | 1,004 | 941 |
| Intangibles | 4,572 | 4,677 | 4,782 | 4,887 | 4,993 |
| Other Non-Current Assets | 1,229 | 851 | 1,025 | 1,101 | 1,147 |
| TOTAL | $6,891 | $6,509 | $6,816 | $6,992 | $7,081 |
| Total Assets | $13,663 | $15,800 | $18,496 | $11,811 | $13,029 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 251 | 338 | N/A |
| Accounts payable and accrued liabilities | 1,434 | 1,194 | 1,655 | 1,780 | 1,209 |
| Accrued Expenses | 783 | 832 | 572 | 311 | 51 |
| TOTAL | $11,758 | $3,538 | $3,658 | $3,613 | $2,542 |
| Non-Current Liabilities | |||||
| Long Term Debt | 204 | 247 | 355 | 282 | 264 |
| Deferred Revenues | 1,173 | 1,177 | 1,180 | 1,184 | 988 |
| Other Non-Current Liabilities | 5,500 | 13,530 | 13,530 | 13,741 | 13,731 |
| TOTAL | $5,704 | $13,777 | $13,885 | $14,023 | $13,995 |
| Total Liabilities | $17,462 | $17,315 | $17,543 | $17,636 | $16,537 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2 | 2 | 2 | 2 | 2 |
| Common Shares | 155 | 155 | 154 | 134 | 133 |
| Retained earnings | -61,562 | -59,134 | -56,581 | -54,227 | -51,593 |
| Other shareholders' equity | -1,395 | -1,420 | -1,426 | -1,329 | -1,395 |
| TOTAL | $-3,799 | $-1,515 | $953 | $-5,825 | $-3,508 |
| Total Liabilities And Equity | $13,663 | $15,800 | $18,496 | $11,811 | $13,029 |